Poseida Therapeutics Inc (PSTX)
2.785
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
2.785
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Price to Book Value: 2.591 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.587 |
| April 30, 2024 | 2.252 |
| April 29, 2024 | 2.159 |
| April 26, 2024 | 1.982 |
| April 25, 2024 | 1.907 |
| April 24, 2024 | 1.926 |
| April 23, 2024 | 2.010 |
| April 22, 2024 | 2.005 |
| April 19, 2024 | 1.880 |
| April 18, 2024 | 1.861 |
| April 17, 2024 | 1.898 |
| April 16, 2024 | 1.889 |
| April 15, 2024 | 2.261 |
| April 12, 2024 | 2.540 |
| April 11, 2024 | 2.708 |
| April 10, 2024 | 2.596 |
| April 09, 2024 | 2.801 |
| April 08, 2024 | 2.764 |
| April 05, 2024 | 2.782 |
| April 04, 2024 | 2.856 |
| April 03, 2024 | 2.847 |
| April 02, 2024 | 2.698 |
| April 01, 2024 | 2.884 |
| March 28, 2024 | 2.968 |
| March 27, 2024 | 2.866 |
| Date | Value |
|---|---|
| March 26, 2024 | 2.615 |
| March 25, 2024 | 2.829 |
| March 22, 2024 | 2.894 |
| March 21, 2024 | 2.829 |
| March 20, 2024 | 2.764 |
| March 19, 2024 | 2.708 |
| March 18, 2024 | 2.847 |
| March 15, 2024 | 2.996 |
| March 14, 2024 | 3.015 |
| March 13, 2024 | 3.173 |
| March 12, 2024 | 2.950 |
| March 11, 2024 | 3.173 |
| March 08, 2024 | 3.787 |
| March 07, 2024 | 3.192 |
| March 06, 2024 | 3.340 |
| March 05, 2024 | 3.238 |
| March 04, 2024 | 3.429 |
| March 01, 2024 | 3.809 |
| February 29, 2024 | 3.652 |
| February 28, 2024 | 3.431 |
| February 27, 2024 | 3.477 |
| February 26, 2024 | 3.191 |
| February 23, 2024 | 2.997 |
| February 22, 2024 | 2.970 |
| February 21, 2024 | 3.080 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9142
Minimum
Jun 29 2023
5.736
Maximum
Aug 12 2022
2.330
Average
2.305
Median
Nov 20 2020
Price to Book Value Benchmarks
| Biomea Fusion Inc | 2.534 |
| Cartesian Therapeutics Inc | -- |
| Lantern Pharma Inc | 1.402 |
| NovaBay Pharmaceuticals Inc | 1.966 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.882 |
| PEG Ratio | -0.0758 |
| Price | 2.785 |
| Earnings Yield | -49.55% |
| Market Cap | 268.72M |
| PEGY Ratio | -0.0758 |